Which combination of features is most concerning for malignant melanoma?

Prepare effectively for the Physician Assistant Clinical Knowledge Rating and Assessment Tool (PACKRAT) 1 Exam with comprehensive resources, flashcards, and detailed explanations. Ace your test with ease!

Multiple Choice

Which combination of features is most concerning for malignant melanoma?

Explanation:
Look for features that signal malignant transformation in a pigmented lesion. Melanoma commonly presents with asymmetry, meaning one half doesn’t match the other; irregular, notched, or blurred borders; and variation in color within the same lesion (different shades of brown, black, red, blue, or white). When all three of these high-risk patterns appear together, the concern for melanoma is greatest and prompt evaluation is important. Benign lesions, by contrast, tend to be symmetric, with smooth, well-defined borders and uniform color, making the other combination much less likely. Size alone isn’t reliable—some melanomas are small—so the presence of multiple suspicious features carries more weight than tiny size. If a lesion shows these concerning patterns, urgent assessment and possible biopsy are warranted.

Look for features that signal malignant transformation in a pigmented lesion. Melanoma commonly presents with asymmetry, meaning one half doesn’t match the other; irregular, notched, or blurred borders; and variation in color within the same lesion (different shades of brown, black, red, blue, or white). When all three of these high-risk patterns appear together, the concern for melanoma is greatest and prompt evaluation is important.

Benign lesions, by contrast, tend to be symmetric, with smooth, well-defined borders and uniform color, making the other combination much less likely. Size alone isn’t reliable—some melanomas are small—so the presence of multiple suspicious features carries more weight than tiny size. If a lesion shows these concerning patterns, urgent assessment and possible biopsy are warranted.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy